BlackRock Health Sciences Term Trust (NYSE:BMEZ) Position Trimmed by Quarry LP

Quarry LP decreased its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 11.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 87,924 shares of the company’s stock after selling 10,962 shares during the period. Quarry LP’s holdings in BlackRock Health Sciences Term Trust were worth $1,393,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Brown Brothers Harriman & Co. bought a new stake in BlackRock Health Sciences Term Trust during the third quarter valued at $32,000. Penserra Capital Management LLC bought a new stake in BlackRock Health Sciences Term Trust during the third quarter valued at $15,390,000. Oppenheimer & Co. Inc. increased its stake in BlackRock Health Sciences Term Trust by 0.6% during the third quarter. Oppenheimer & Co. Inc. now owns 204,354 shares of the company’s stock valued at $3,237,000 after purchasing an additional 1,153 shares during the last quarter. Dakota Wealth Management increased its stake in BlackRock Health Sciences Term Trust by 23.4% during the third quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock valued at $357,000 after purchasing an additional 4,267 shares during the last quarter. Finally, Brown Lisle Cummings Inc. boosted its holdings in shares of BlackRock Health Sciences Term Trust by 6.2% during the third quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock valued at $578,000 after acquiring an additional 2,128 shares during the period.

Insider Activity

In related news, major shareholder Saba Capital Management, L.P. acquired 27,148 shares of BlackRock Health Sciences Term Trust stock in a transaction that occurred on Tuesday, September 17th. The stock was acquired at an average price of 15.93 per share, with a total value of 432,467.64. Following the completion of the acquisition, the insider now directly owns 20,565,579 shares of the company’s stock, valued at 327,609,673.47. This trade represents a 0.13 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Over the last quarter, insiders bought 99,630 shares of company stock valued at $1,585,113.

BlackRock Health Sciences Term Trust Price Performance

Shares of BMEZ opened at 15.57 on Thursday. BlackRock Health Sciences Term Trust has a 1 year low of 14.08 and a 1 year high of 16.59. The firm has a fifty day moving average of 15.63 and a 200-day moving average of 15.60.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently declared a monthly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were issued a dividend of $0.1769 per share. This represents a $2.12 annualized dividend and a dividend yield of 13.63%. The ex-dividend date of this dividend was Friday, November 15th.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.